Tag: protease-cleavable linker
U.S. FDA Accepts Priority Review of Tisotumab Vedotin BLA for Patients...
Each year more than 13,500 women in the United States are diagnosed with invasive cervical cancer and approximately 4,200 will die of the disease....
AACR 2020: A Next Generation of FRα-Targeting ADC Engineered to Maximize...
Preclinical data for ImmunoGen's next-generation anti-folate receptor alpha (FRα) ADC, IMGN151, which is being investigated in tumors with a broad range of FRα expression...
Brentuximab Vedotin Approved by Health Canada for Post-ASCT Consolidation Treatment of...
Health Canada, the federal department responsible for helping Canadians maintain and improve their health, has issued a non-conditional marketing authorization for use of brentuximab...
